-+ 0.00%
-+ 0.00%
-+ 0.00%

Alto Neuroscience Q2 EPS $(0.65) Beats $(0.73) Estimate

Benzinga·08/12/2026 20:19:07
Listen to the news
Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.73) by 10.96 percent. This is unchanged from the same period last year.